0001752724-24-116390.txt : 20240523 0001752724-24-116390.hdr.sgml : 20240523 20240523164624 ACCESSION NUMBER: 0001752724-24-116390 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 PERIOD START: 20240630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIDELITY COVINGTON TRUST CENTRAL INDEX KEY: 0000945908 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-07319 FILM NUMBER: 24979081 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-563-7000 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 0000945908 S000073599 Fidelity Digital Health ETF C000230604 Fidelity Digital Health ETF FDHT NPORT-P 1 primary_doc.xml NPORT-P false 0000945908 XXXXXXXX S000073599 C000230604 Fidelity Covington Trust 811-07319 0000945908 549300JFYFTF85QAQR28 245 Summer Street Boston 02210 1-800-FIDELITY Fidelity Digital Health ETF S000073599 549300MMZ4CERW33MZ22 2024-06-30 2024-03-31 N 9716491.43 3116.60 9713374.83 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 2827.90000000 N HIMS and HERS HEALTH INC 549300ZQ4ZUYSAAX6P59 HIMS and HERS HEALTH INC 433000106 13060.00000000 NS USD 202038.20000000 2.080000036403 Long EC CORP US N 1 N N N IQVIA HOLDINGS INC 549300W3R20NM4KQPH86 IQVIA HOLDINGS INC 46266C105 802.00000000 NS USD 202817.78000000 2.088025877201 Long EC CORP US N 1 N N N JMDC INC 3538002M2SQV6WJ6MQ67 JMDC INC N/A 4700.00000000 NS 113381.35000000 1.167270407910 Long EC CORP JP N 1 N N N SECTRA AB 549300R9ZBT8YSFFK266 SECTRA AB SER B N/A 9554.00000000 NS 185091.66000000 1.905534000688 Long EC CORP SE N 1 N N N ACCOLADE INC 549300PHKG8J7A22NF08 ACCOLADE INC 00437E102 11949.00000000 NS USD 125225.52000000 1.289207121022 Long EC CORP US N 1 N N N NIHON KOHDEN CORP N/A NIHON KOHDEN CORP N/A 6700.00000000 NS 177477.29000000 1.827143429612 Long EC CORP JP N 1 N N N DOCMORRIS AG 50670038OH136R5Z4663 DOCMORRIS AG N/A 1588.00000000 NS 159646.28000000 1.643571701844 Long EC CORP CH N 1 N N N TALKSPACE INC N/A TALKSPACE INC CL A 87427V103 34330.00000000 NS USD 122558.10000000 1.261745810750 Long EC CORP US N 1 N N N RESMED INC 529900T3QE5253CCXF22 RESMED INC 761152107 2327.00000000 NS USD 460815.81000000 4.744137007631 Long EC CORP US N 1 N N N PREMIER INC N/A PREMIER INC 74051N102 8924.00000000 NS USD 197220.40000000 2.030400385568 Long EC CORP US N 1 N N N HEALTH CATALYST INC 549300223PL6GWKVJG92 HEALTH CATALYST INC 42225T107 12903.00000000 NS USD 97159.59000000 1.000266042446 Long EC CORP US N 1 N N N PHREESIA INC 5493000HHF8NU4QOCG53 PHREESIA INC 71944F106 6048.00000000 NS USD 144728.64000000 1.489993360011 Long EC CORP US N 1 N N N CIGNA GROUP (THE) 549300VIWYMSIGT1U456 CIGNA GROUP (THE) 125523100 590.00000000 NS USD 214282.10000000 2.206052003040 Long EC CORP US N 1 N N N SONOVA HLDG AG 5299004A0QNX7FBNHS61 SONOVA HLDG AG N/A 1088.00000000 NS 315395.58000000 3.247023671174 Long EC CORP CH N 1 N N N ALIBABA HEALTH INFORMATION TECHNOLOGY LTD 529900GE9653COPX1I86 ALIBABA HEALTH INFORMATION TECHNOLOGY LTD N/A 406000.00000000 NS 164963.68000000 1.698314776142 Long EC CORP BM N 1 N N N JD HEALTH INTERNATIONAL INC 254900OM3MAXYK8PCC84 JD HEALTH INTERNATIONAL INC N/A 56600.00000000 NS 200323.26000000 2.062344586778 Long EC CORP KY N 1 N N N I-SENS INC N/A I-SENS INC N/A 5365.00000000 NS 79702.88000000 0.820547764241 Long EC CORP KR N 1 N N N COCHLEAR LTD 5493001OLLWY8KV5UC08 COCHLEAR LTD N/A 1482.00000000 NS 326333.51000000 3.359630568276 Long EC CORP AU N 1 N N N EVOLENT HEALTH INC 549300CZOCFHQ2BBTR11 EVOLENT HEALTH INC A 30050B101 6369.00000000 NS USD 208839.51000000 2.150020087302 Long EC CORP US N 1 N N N KONINKLIJKE PHILIPS NV H1FJE8H61JGM1JSGM897 KONINKLIJKE PHILIPS NV N/A 18130.00000000 NS 364312.92000000 3.750631746185 Long EC CORP NL N 1 N N N TELADOC HEALTH INC 549300I2PVFBC9MFAC61 TELADOC HEALTH INC 87918A105 12344.00000000 NS USD 186394.40000000 1.918945817104 Long EC CORP US N 1 N N N DEMANT A/S 213800RM6L9LN78BVA56 DEMANT A/S N/A 4592.00000000 NS 228054.15000000 2.347836400749 Long EC CORP DK N 1 N N N MAXIMUS INC 549300DQCDS8HJ7QF202 MAXIMUS INC 577933104 2820.00000000 NS USD 236598.00000000 2.435796045564 Long EC CORP US N 1 N N N AXONICS INC 549300LJY4X7N57VJL05 AXONICS INC 05465P101 3049.00000000 NS USD 210289.53000000 2.164948163541 Long EC CORP US N 1 N N N CORVEL CORP N/A CORVEL CORP 221006109 733.00000000 NS USD 192749.68000000 1.984373952137 Long EC CORP US N 1 N N N INTUITIVE SURGICAL INC 54930052SRG011710797 INTUITIVE SURGICAL INC 46120E602 1119.00000000 NS USD 446581.71000000 4.597595766825 Long EC CORP US N 1 N N N DEXCOM INC 549300YSK3QDSFR5EU59 DEXCOM INC 252131107 3749.00000000 NS USD 519986.30000000 5.353302112814 Long EC CORP US N 1 N N N IRHYTHM TECHNOLOGIES INC 549300FJI72RJGDQS384 IRHYTHM TECHNOLOGIES INC 450056106 1778.00000000 NS USD 206248.00000000 2.123340276779 Long EC CORP US N 1 N N N ASTRANA HEALTH INC 5493008O4R82Q4STJ936 ASTRANA HEALTH INC 03763A207 3754.00000000 NS USD 157630.46000000 1.622818667649 Long EC CORP US N 1 N N N NEVRO CORP 254900SH91I4BOYKUE38 NEVRO CORPORATION 64157F103 7607.00000000 NS USD 109845.08000000 1.130864214780 Long EC CORP US N 1 N N N GOODRX HOLDINGS INC N/A GOODRX HOLDINGS INC 38246G108 14954.00000000 NS USD 106173.40000000 1.093063964463 Long EC CORP US N 1 N N N R1 RCM INC. N/A R1 RCM INC 77634L105 13711.00000000 NS USD 176597.68000000 1.818087771662 Long EC CORP US N 1 N N N DOXIMITY INC N/A DOXIMITY INC 26622P107 7263.00000000 NS USD 195447.33000000 2.012146482768 Long EC CORP US N 1 N N N TANDEM DIABETES CARE INC 549300JEPFOD0K4D3I05 TANDEM DIABETES CARE INC 875372203 6189.00000000 NS USD 219152.49000000 2.256193072289 Long EC CORP US N 1 N N N PRO MEDICUS LTD N/A PRO MEDICUS LTD N/A 3091.00000000 NS 209218.97000000 2.153926659494 Long EC CORP AU N 1 N N N REDCARE PHARMACY NV 529900JK6UXHY1YKZ082 REDCARE PHARMACY NV N/A 1232.00000000 NS 201779.42000000 2.077335874826 Long EC CORP NL N 1 N N N COMPUGROUP MEDICAL SE and CO KGAA 529900CUXZGOCJZR7O57 COMPUGROUP MEDICAL SE and CO KGA N/A 4097.00000000 NS 126194.15000000 1.299179247260 Long EC CORP DE N 1 N N N VEEVA SYS INC 549300YZEXPDB92M2F02 VEEVA SYS INC CL A 922475108 1951.00000000 NS USD 452027.19000000 4.653657435352 Long EC CORP US N 1 N N N INSPIRE MEDICAL SYSTEMS INC 549300XQQCQ7HCJKTW25 INSPIRE MEDICAL SYSTEMS INC 457730109 1335.00000000 NS USD 286744.65000000 2.952059969047 Long EC CORP US N 1 N N N DEFINITIVE HEALTHCARE CORP N/A DEFINITIVE HEALTHCARE CORP 24477E103 11168.00000000 NS USD 90125.76000000 0.927852178849 Long EC CORP US N 1 N N N INSULET CORP 549300TZTYD2PYN92D43 INSULET CORP 45784P101 1886.00000000 NS USD 323260.40000000 3.327992645785 Long EC CORP US N 1 N N N PING AN HEALTHCARE AND TECHNOLOGY CO LTD 2549009NW1LO017CP285 PING AN HEALTHCARE AND TECHNOLOGY CO LTD N/A 84900.00000000 NS 128004.40000000 1.317815921245 Long EC CORP KY N 1 N N N COGNIZANT TECHNOLOGY SOLUTIONS CORP 5493006IEVQEFQO40L83 COGNIZANT TECH SOLUTIONS CL A 192446102 2509.00000000 NS USD 183884.61000000 1.893107320764 Long EC CORP US N 1 N N N FISHER and PAYKEL HEALTHCARE CORP N/A FISHER and PAYKEL HEALTHCARE CORP N/A 18900.00000000 NS 289974.15000000 2.985307939568 Long EC CORP NZ N 1 N N N OMNICELL INC 5493008RH0GTKHHPZI77 OMNICELL INC 68213N109 5546.00000000 NS USD 162109.58000000 1.668931579777 Long EC CORP US N 1 N N N 2024-04-30 Stacie M. Smith Stacie M. Smith Stacie M. Smith President and Treasurer XXXX NPORT-EX 2 QTLY_6444_20240331.htm 010 - Quarterly Front Cover
Quarterly Holdings Report
for
Fidelity® Digital Health ETF
March 31, 2024
DHE-NPRT3-0524
1.9903839.102
Common Stocks - 99.9%
 
  
Shares
Value ($)
 
CONSUMER STAPLES - 8.8%
 
  
  
Consumer Staples Distribution & Retail - 8.8%
  
  
  
Alibaba Health Information Technology Ltd. (a)
  
406,000
164,964
DocMorris AG (a)
  
1,588
159,646
JD Health International, Inc. (a)(b)
  
56,600
200,323
Ping An Healthcare and Technology Co. Ltd. (a)(b)
  
84,900
128,004
Redcare Pharmacy NV (a)(b)
  
1,232
201,779
 
  
  
854,716
HEALTH CARE - 86.8%
 
  
  
Health Care Equipment & Supplies - 48.6%
  
  
  
Axonics, Inc. (a)
  
3,049
210,290
Cochlear Ltd.
 
1,482
326,334
Demant A/S (a)
  
4,592
228,054
DexCom, Inc. (a)
  
3,749
519,986
Fisher & Paykel Healthcare Corp.
 
18,900
289,974
I-Sens, Inc.
 
5,365
79,703
Inspire Medical Systems, Inc. (a)
  
1,335
286,745
Insulet Corp. (a)
  
1,886
323,260
Intuitive Surgical, Inc. (a)
  
1,119
446,582
iRhythm Technologies, Inc. (a)
  
1,778
206,248
Koninklijke Philips Electronics NV
 
18,130
364,313
Nevro Corp. (a)
  
7,607
109,845
Nihon Kohden Corp.
 
6,700
177,477
Omnicell, Inc. (a)
  
5,546
162,110
ResMed, Inc.
 
2,327
460,816
Sonova Holding AG
 
1,088
315,396
Tandem Diabetes Care, Inc. (a)
  
6,189
219,152
 
  
  
4,726,285
Health Care Providers & Services - 14.3%
  
  
  
Accolade, Inc. (a)
  
11,949
125,226
Astrana Health, Inc. (a)
  
3,754
157,630
Cigna Group
 
590
214,282
Corvel Corp. (a)
  
733
192,750
Hims & Hers Health, Inc. (a)
  
13,060
202,038
Premier, Inc.
 
8,924
197,220
R1 RCM, Inc. (a)
  
13,711
176,598
Talkspace, Inc. Class A (a)
  
34,330
122,558
 
  
  
1,388,302
Health Care Technology - 21.8%
  
  
  
CompuGroup Medical AG
 
4,097
126,194
Definitive Healthcare Corp. (a)
  
11,168
90,126
Doximity, Inc. (a)
  
7,263
195,447
Evolent Health, Inc. Class A (a)
  
6,369
208,840
GoodRx Holdings, Inc. (a)
  
14,954
106,173
Health Catalyst, Inc. (a)
  
12,903
97,160
JMDC, Inc.
 
4,700
113,381
Phreesia, Inc. (a)
  
6,048
144,729
Pro Medicus Ltd.
 
3,091
209,219
Sectra AB (B Shares)
 
9,554
185,092
Teladoc Health, Inc. (a)
  
12,344
186,394
Veeva Systems, Inc. Class A (a)
  
1,951
452,027
 
  
  
2,114,782
Life Sciences Tools & Services - 2.1%
  
  
  
IQVIA Holdings, Inc. (a)
  
802
202,818
TOTAL HEALTH CARE
  
  
8,432,187
INDUSTRIALS - 2.4%
 
  
  
Professional Services - 2.4%
  
  
  
Maximus, Inc.
 
2,820
236,598
INFORMATION TECHNOLOGY - 1.9%
 
  
  
IT Services - 1.9%
  
  
  
Cognizant Technology Solutions Corp. Class A
 
2,509
183,885
 
TOTAL COMMON STOCKS
 (Cost $10,334,305)
  
  
  
9,707,386
 
  
  
  
 
TOTAL INVESTMENT IN SECURITIES - 99.9%
 (Cost $10,334,305)
 
  
 
9,707,386
NET OTHER ASSETS (LIABILITIES) - 0.1%  
5,989
NET ASSETS - 100.0%
9,713,375
 
  
Legend
 
(a)
Non-income producing
 
(b)
Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $530,106 or 5.5% of net assets.
 
 
 
 
Affiliated Central Funds
 
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
 
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
% ownership,
end
of period
Fidelity Cash Central Fund 5.39%
-
171,342
171,342
26
-
-
-
0.0%
Total
-
171,342
171,342
26
-
-
-
  
 
  
  
  
  
  
  
  
  
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
 
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.   
 
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
 
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
 
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
 
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
 
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
 
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
 
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.